A possible new application for the successful vaccine:
The Food and Drug Administration approved the HPV vaccine last year for girls and women from 9 to 26 after studies indicated that it was extremely effective against infection by four of the dozens of strains of HPV, including the ones responsible for most cases of cervical and anal cancer, as well as genital and anal warts.“The cervix is similar biologically to the anus, so there’s plenty of hope that it will work there also,” said Dr. Joel Palefsky, a professor of medicine at the University of California, San Francisco.
